Neurotensin and neurotensin receptor 1 expression in human myometrium and uterine leiomyomas

Biology of Reproduction

Volumn 83, Issue 4, 2010, Pages 641-647

  Rodríguez, Yurena ^a,e   Almeida, Teresa A ^a,e   Valladares, Francisco ^b,e   Báez, Delia ^b,c,e   De Oca, Francisco Montes ^d   García, Candelaria ^c,e   Dorta, Idaira ^a,e   Hernández, Mariano ^a,e   Reyes, Ricardo ^a,e   Bello, Aixa R ^a,e  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^d Hospital USP La Colina   (Spain)

^e Madrid Spain   (Spain)

Author keywords

Female reproductive tract; Immunohistochemistry; Leiomyoma; Myometrium; Neuropeptides; Neurotensin; Neurotensin receptor 1; NTS mRNA expression; Splice variants; Steroid hormone receptors; Steroid hormones; Uterus

Indexed keywords

NEUROTENSIN; NEUROTENSIN RECEPTOR; STEROID;

ADULT; ALTERNATIVE RNA SPLICING; ARTICLE; CANCER CELL; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FERTILIZATION IN VITRO; GENETIC TRANSCRIPTION; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; TUMOR GROWTH; UTERUS MYOMA;

ADULT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LEIOMYOMA; MIDDLE AGED; MYOMETRIUM; NEUROTENSIN; RECEPTORS, NEUROTENSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; UTERINE NEOPLASMS;

EID: 77957585277     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.110.084962     Document Type: Article

References (28)

1. Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 2008; 22:571-588. (Pubitemid 351804127)
2. Xu Q, Takekida S, Ohara N, Chen W, Sitruk-Ware R, Johansson ED, Mauro T. Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and upregulates caspase-3 and poly(adenosine 5′-diphosphate-ribose) polymerase expression in cultured human uterine leiomyoma cells. J Clin Endocrinol Metab 2005; 90:953-956.
3. Yin P, Lin Z, Cheng YH, Marsh EE, Utsunomiya H, Ishikawa H, Xue Q, Reierstad S, Innes J, Thung S, Kim JJ, Xu E, et al. Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells. J Clin Endocrinol Metab 2007; 92:4459-4466.
4. Hyder SM, Stancel GM. Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins. Mol Endocrinol 1999; 13:806-811.
5. Dupouy S, Viardot-Foucault V, Alifano M, Souazé F, Plu-Bureau G, Chaouat M, Lavaur A, Hugol D, Gespach C, Gompel A, Forgez P. The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression. PLoS One 2009; 4:e4223.
6. Vincent JP, Mazella J, Kitabgi P. Neurotensin and neurotensin receptors. Trends Pharmacol Sci 1999; 20:302-309.
7. Evers BM. Neurotensin and growth of normal and neoplastic tissues. Peptides 2006; 27:2424-2433. (Pubitemid 44429934)
8. Reubi JC, Waser B, Schaer JC, Laissue JA. Neurotensin receptors in human neoplasms: high incidence in Ewing's sarcomas. Int J Cancer 1999; 82:213-218. (Pubitemid 29293780)
9. Elek J, Pinzon W, Park KH, Narayanan R. Relevant genomics of neurotensin receptor in cancer. Anticancer Res 2000; 20:53-58. (Pubitemid 30189733)
10. Sehgal I, Powers S, Huntley B, Powis G, Pittelkow M, Maihle NJ. Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer. Proc Natl Acad Sci U S A 1994; 91:4673-4677.
11. Seethalakshmi L, Mitra SP, Dobner PR, Menon M, Carraway RE. Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations. Prostate 1997; 31:183-192.
12. Carraway RE, Hassan S. Neurotensin receptor binding and neurotensin-induced growth signaling in prostate cancer PC3 cells are sensitive to metabolic stress. Regul Pept 2007; 7:140-153.
13. Carraway RE, Plona AM. Involvement of neurotensin in cancer growth: evidence, mechanisms and development of diagnostic tools. Peptides 2006; 27:2445-2460.
14. Dong Z, Wang X, Zhao Q, Townsend CM Jr, Evers BM. DNA methylation contributes to expression of the human neurotensin/neuromedin N gene. Am J Physiol 1998; 274:G535-G543.
15. Gui X, Guzman G, Dobner PR, Kadkol SS. Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma. Peptides 2008; 29:1609-1615.
16. Giorgi RR, Chile T, Bello AR, Reyes R, Fortes MA, Machado MC, Cescato VA, Musolino NR, Bronstein MD, Giannella-Neto D, Corrêa-Giannella ML. Expression of neurotensin and its receptors in pituitary adenomas. J Neuroendocrinol 2008; 20:1052-1057.
17. Almeida TA, Rodriguez Y, Hernández M, Reyes R, Bello AR. Differential expression of new splice variants of the neurotensin receptor 1 gene in human prostate cancer cell lines. Peptides 2010; 31:242-247.
18. Studler JM, Kitabgi P, Tramu G, Herve D, Glowinski J, Tassin JP. Extensive co-localization of neurotensin with dopamine in rat mesocortico-frontal dopaminergic neurons. Neuropeptides 1988; 11:95-100.
19. Bello AR, Reyes R, Hernández G, Negrín I, González M, Tramu G, Alonso R. Developmental expression of neurotensin in thyrotropes and gonadotropes of male and female rats. Neuroendocrinology 2004; 79:90-99.
20. Tramu G, Pillez A, Leonardelli J. An efficient method of antibody elution for the successive or simultaneous localization of two antigens by immunocytochemistry. J Histochem Cytochem 1978; 26:322-324.
21. Souazé F, Forgez P. Molecular and cellular regulation of neurotensin receptor under acute and chronic agonist stimulation. Peptides 2006; 27:2493-2501.
22. Franco OE, Shaw AK, Strand DW, Hayward SW. Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol 2009; 21:33-39.
23. Alexander MJ, Leeman SE. Estrogen-inducible neurotensin immunoreactivity in the preoptic area of the female rat. J Comp Neurol 1994; 345:496-509.
24. Souazé F, Viardot-Foucault V, Roullet N, Toy-Miou-Leong M, Gompel A, Bruyneel E, Comperat E, Faux MC, Mareel M, Rostène W, Fléjou JF, Gespach C, Forgez P. Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas. Carcinogenesis 2006; 27:708-716.
25. Theodorsson-Norheim E, Oberg K, Rosell S, Boström H. Neurotensinlike immunoreactivity in plasma and tumor tissue from patients with endocrine tumors of the pancreas and gut. Gastroenterology 1983; 85:881-889.
26. Reubi JC, Waser B, Friess H, Büchler M, Laissue J. Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma. Gut 1998; 42:546-550.
27. Wang L, Friess H, Zhu Z, Graber H, Zimmermann A, Korc M, Reubi JC, Büchler MW. Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease. Clin Cancer Res 2000; 6:566-571.
28. Venables JP. Aberrant and alternative splicing in cancer. Cancer Res 2004; 64:7647-7654.